Jacobs Levy Equity Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-19,107
| Closed | -$113K | – | 1143 |
|
|
2020
Q3 | $113K | Sell |
19,107
-140,517
| -88% | -$831K | ﹤0.01% | 994 |
|
|
2020
Q2 | $822K | Sell |
159,624
-24,905
| -13% | -$128K | 0.01% | 708 |
|
|
2020
Q1 | $668K | Buy |
184,529
+39,104
| +27% | +$142K | 0.01% | 708 |
|
|
2019
Q4 | $908K | Buy |
+145,425
| New | +$908K | 0.01% | 705 |
|
|
2017
Q2 | – | Sell |
-7,140
| Closed | -$42K | – | 1054 |
|
|
2017
Q1 | $42K | Sell |
7,140
-21,813
| -75% | -$128K | ﹤0.01% | 899 |
|
|
2016
Q4 | $156K | Sell |
28,953
-1,660
| -5% | -$8.94K | ﹤0.01% | 856 |
|
|
2016
Q3 | $272K | Buy |
30,613
+1,690
| +6% | +$15K | ﹤0.01% | 833 |
|
|
2016
Q2 | $278K | Hold |
28,923
| – | – | 0.01% | 904 |
|
|
2016
Q1 | $266K | Sell |
28,923
-7,658
| -21% | -$70.4K | 0.01% | 906 |
|
|
2015
Q4 | $461K | Buy |
36,581
+32,071
| +711% | +$404K | 0.01% | 568 |
|
|
2015
Q3 | $55K | Buy |
4,510
+1,000
| +28% | +$12.2K | ﹤0.01% | 786 |
|
|
2015
Q2 | $61K | Sell |
3,510
-9,572
| -73% | -$166K | ﹤0.01% | 779 |
|
|
2015
Q1 | $190K | Buy |
13,082
+4,502
| +52% | +$65.4K | ﹤0.01% | 708 |
|
|
2014
Q4 | $72K | Sell |
8,580
-12,949
| -60% | -$109K | ﹤0.01% | 793 |
|
|
2014
Q3 | $239K | Buy |
+21,529
| New | +$239K | ﹤0.01% | 722 |
|